Gynecologic Oncology Group
In research, Gynecologic Oncology Group stands highest in Medicine (#6,311 of 10,443 worldwide) and Health Sciences (#7,370 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Obstetrics and Gynecology — Obstetrics and Gynecology is 63.1× its share of world research.
- World rank, 2022–2025
- #16,466 of 28,054 · #9,745 all time
- Rank in United States
- #2,344 of 4,192
- Research works
- 1.2k ▼ 15% vs 2013–17
- Citations
- 50k 41.6 per fractional work
- Top-10% rate
- 11.4% record average 16.5%
- Open access
- 31% world 28%
What is Gynecologic Oncology Group known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #6,311 of 10,443 | 11.2% | 122 | #2630 | |
| Health SciencesDomain | #7,370 of 11,982 | 11.1% | 127 | #3565 |
Each strip is that field’s whole ranked pool, with the notch where Gynecologic Oncology Group sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Gynecologic Oncology Group specialise in?
Where its research is concentrated relative to its size: Obstetrics and Gynecology takes 63.1× the share of its output that it takes of world research.
- Obstetrics and GynecologySubfield · 28.6 works63×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.
- Medicine 4.0×
- Biochemistry, Genetics and Molecular Biology 1.8×
- Immunology and Microbiology 1.5×
- Health Professions 0.9×
- Pharmacology, Toxicology and Pharmaceutics 0.8×
- Psychology 0.6×
- Nursing 0.4×
- Economics, Econometrics and Finance 0.4×
- Arts and Humanities 0.3×
- Chemistry 0.2×
- Environmental Science 0.2×
- Social Sciences 0.2×
- Neuroscience 0.1×
- Dentistry 0.1×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.0×
- Mathematics 0.0×
- Business, Management and Accounting 0.0×
- Computer Science 0.0×
- Materials Science 0.0×
- Physics and Astronomy 0.0×
- Decision Sciences 0.0×
Who are the top researchers at Gynecologic Oncology Group?
Ranked on the composite score, John A. Blessing, Brian N. Bundy and Young Rc lead among researchers whose main affiliation is Gynecologic Oncology Group.
- 1 John A. Blessing United States · #55,873 worldwide 324 citations · 35 works
- 2 Brian N. Bundy United States · #61,597 worldwide 329 citations · 28 works
- 3 Young Rc United States · #202,346 worldwide 134 citations · 19 works
- 4 J. S. Berek United States · #314,456 worldwide 80 citations · 17 works
- 5 Heather A. Lankes United States · #404,738 worldwide 32 citations · 29 works
- 6 Bruce Patsner United States · #700,141 worldwide 16 citations · 22 works
- 7 Maria C. Bell United States · #827,748 worldwide 15 citations · 16 works
Which keywords describe research at Gynecologic Oncology Group?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Cervical Cancer, Survival Analysis, Clinical Practice Guidelines, Robotic Surgery, Radiation Therapy, Sentinel Lymph Node Biopsy and Molecular Classification.
- Reproductive Outcome
- Cell Death
- Prenatal Diagnosis
- Cancer Therapy
- Uterine Fibroids
- Immunotherapy
- Health-related Quality of Life
- Cytology Screening
- Global Burden
- Human Papillomavirus
- Quality of Life
- Mutation Analysis
- Biomarkers
- Ovarian Cancer
- Molecular Classification
- Clinical Trials
- Sentinel Lymph Node Biopsy
- Robotic Surgery
- Epidemiology
- Cervical Cancer
- Chemotherapy
- Survival Analysis
- Clinical Practice Guidelines
- Radiation Therapy
- Brachytherapy
- Endometrial Carcinoma
- Cytoreductive Surgery
- Metastasis
- Genomic Analysis
- Tumor Models
- Cancer Incidence
- Breast Cancer
- Diagnosis
- HPV Vaccination
- Management
- Maternal Mortality
- Uterine Leiomyoma
- Infertility
- Homologous Recombination
- Surgical Treatment
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy24▲ 22×17 topics
- Cervical Cancer24▲ 144×3 topics
- Survival Analysis20▲ 47×6 topics
- Epidemiology20▲ 3.2×20 topics
- Clinical Practice Guidelines20▲ 23×9 topics
- Robotic Surgery18▲ 81×5 topics
- Radiation Therapy17▲ 81×4 topics
- Sentinel Lymph Node Biopsy17▲ 126×2 topics
- Brachytherapy16▲ 258×1 topic
- Clinical Trials16▲ 15×10 topics
- Endometrial Carcinoma16▲ 258×1 topic
- Molecular Classification16▲ 69×2 topics
- Cytoreductive Surgery16▲ 153×2 topics
- Ovarian Cancer16▲ 112×3 topics
- Metastasis15▲ 29×8 topics
- Biomarkers15▲ 14×8 topics
- Genomic Analysis13▲ 34×2 topics
- Mutation Analysis13▲ 113×1 topic
- Tumor Models13▲ 144×1 topic
- Quality of Life9▲ 4.1×13 topics
- Cancer Incidence9▲ 42×4 topics
- Human Papillomavirus8▲ 41×3 topics
- Breast Cancer7▲ 20×11 topics
- Global Burden7▲ 8.7×3 topics
- Diagnosis7▲ 5.0×12 topics
- Cytology Screening7▲ 94×1 topic
- HPV Vaccination7▲ 94×1 topic
- Health-related Quality of Life7▲ 19×3 topics
- Management6▲ 4.5×8 topics
- Immunotherapy5▲ 4.6×12 topics
- Maternal Mortality5▲ 15×5 topics
- Uterine Fibroids5▲ 110×1 topic
- Uterine Leiomyoma5▲ 110×1 topic
- Cancer Therapy5▲ 5.2×9 topics
- Infertility5▲ 21×4 topics
- Prenatal Diagnosis4▲ 18×5 topics
- Homologous Recombination4▲ 57×2 topics
- Cell Death4▲ 11×3 topics
- Surgical Treatment4▲ 13×4 topics
- Reproductive Outcome4▲ 63×2 topics
Which research topics does Gynecologic Oncology Group publish most on?
By volume in 2022–2025: Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Cervical Cancer and HPV Research and Uterine Myomas and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 16 works
- 2 Ovarian cancer diagnosis and treatment Reproductive Medicine 13 works
- 3 Cervical Cancer and HPV Research Epidemiology 7 works
- 4 Uterine Myomas and Treatments Obstetrics and Gynecology 5 works
- 5 PARP inhibition in cancer therapy Oncology 4 works
- 6 Gynecological conditions and treatments Obstetrics and Gynecology 4 works
- 7 Global Maternal and Child Health Pediatrics, Perinatology and Child Health 3 works
- 8 Endometriosis Research and Treatment Reproductive Medicine 3 works
- 9 Intraperitoneal and Appendiceal Malignancies Surgery 2 works
- 10 Gestational Trophoblastic Disease Studies Public Health, Environmental and Occupational Health 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Gynecologic Oncology Group's research output changed?
Output in 2018–2022 was 15% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Crofton
- User Systems (United States)
- Association of Professors of Gynecology and Obstetrics
- Maryland Aerospace (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.